Masini, S., Antoñanzas Basa, M., Calles, A., Cabellos, R. A., De Elejoste Echebarria, I., Traseira Puchol, C., . . . Baena, J. (2025). Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) with PD-L1 Expression ≥ 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study).
Citação norma ChicagoMasini, Silvia, et al. Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) With PD-L1 Expression ≥ 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study). 2025.
Citação norma MLAMasini, Silvia, et al. Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) With PD-L1 Expression ≥ 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study). 2025.